← Back to Search

Genetic Counseling Sequence for Heart Disease (RESEQUENCEGC Trial)

N/A
Waitlist Available
Led By Cynthia James
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Clinical diagnosis or suspected clinical diagnosis of a potentially inherited cardiovascular disease including hypertrophic, dilated, or arrhythmogenic cardiomyopathy, ventricular or atrial arrhythmias, or an ECG-pattern suspicious for an inherited cardiovascular disease including catecholaminergic polymorphic ventricular tachycardia, long QT syndrome, or Brugada syndrome, or a diagnosed or suspected lipid disorder or early-onset coronary artery disease
Documented pathogenic or likely pathogenic variant in a gene associated with a hereditary cardiomyopathy, arrhythmia syndrome, or lipid disease in a family member
Must not have
Previous genetic testing that definitively identified the genetic cause of the patient's condition
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6-months post results disclosure
Awards & highlights
No Placebo-Only Group

Summary

This trialwill test whether tailored pre-test genetic counseling followed by post-test counseling increases efficiency and improves outcomes for those seeking genetic testing for medical management.

Who is the study for?
Adults over 18 with suspected or diagnosed inherited heart conditions, including various cardiomyopathies, arrhythmias, lipid disorders, or early-onset coronary artery disease. They must be scheduled for genetic counseling at the Johns Hopkins Center and have not had previous genetic counseling/testing for their condition there.
What is being tested?
The trial is testing a new approach to cardiovascular genetic counseling by providing pre-test education via video and post-test counseling sessions. It compares usual care with two other methods: one where a call with a counselor before testing is optional and another where it's required.
What are the potential side effects?
This study does not involve medication; therefore, traditional side effects are not applicable. However, participants may experience psychological impacts from learning about their genetic risks.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I may have a genetic heart condition or early heart disease.
Select...
A family member has a genetic heart or lipid condition.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My condition's genetic cause has been identified through testing.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6-months post results disclosure
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6-months post results disclosure for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Anxiety as measured on the Hospital Anxiety and Depression Scale (HADS)
Change in empowerment as measured on the Genetic Counseling Outcomes Scale (GCOS)
Efficiency as assessed by minutes of counseling time
+1 more
Secondary study objectives
Change in engagement as assessed by Patient Activation Measure
Informed Choice as assessed by Multidimensional Model of informed Choice pilot scales

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: FlippedExperimental Treatment2 Interventions
Pre-test genetics education by educational video with a REQUIRED call with a genetic counselor to address questions. Pre-test appointment available by request. Post-test genetic counseling appointment.
Group II: EfficiencyExperimental Treatment2 Interventions
Pre-test genetics education by educational video with an OPTIONAL call with a genetic counselor to address questions. Pre-test appointment available by request. Post-test genetic counseling appointment.
Group III: Standard of careActive Control1 Intervention
Pre-test genetic counseling appointment with results returned by phone or EHR. Post-test appointment available upon request.

Find a Location

Who is running the clinical trial?

National Human Genome Research Institute (NHGRI)NIH
270 Previous Clinical Trials
293,559 Total Patients Enrolled
4 Trials studying Genetic Counseling
1,195 Patients Enrolled for Genetic Counseling
Johns Hopkins UniversityLead Sponsor
2,339 Previous Clinical Trials
14,881,163 Total Patients Enrolled
Cynthia JamesPrincipal InvestigatorJohns Hopkins University

Media Library

optional phone call with genetic counselor pre-test Clinical Trial Eligibility Overview. Trial Name: NCT05422573 — N/A
Genetic Counseling Research Study Groups: Efficiency, Standard of care, Flipped
Genetic Counseling Clinical Trial 2023: optional phone call with genetic counselor pre-test Highlights & Side Effects. Trial Name: NCT05422573 — N/A
optional phone call with genetic counselor pre-test 2023 Treatment Timeline for Medical Study. Trial Name: NCT05422573 — N/A
~20 spots leftby Feb 2025